HIV superinfection: Clinical and biological implications;Superinfección por el virus de la inmunodeficiencia humana: Implicaciones clínicas y biológicas

Medicina Clinica

Volumn 121, Issue 5, 2003, Pages 192-196

  Valer, Luisa ^a   de Mendoza, Carmen ^a   Soriano, Vicente ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Coinfection; HIV; Recombination; Subtypes; Superinfection; Vaccines

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS VACCINE;

CLINICAL RESEARCH; EXPOSURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; NONHUMAN; REVIEW; SUPERINFECTION; VIRUS IMMUNITY; VIRUS PARTICLE; VIRUS RECOMBINANT; VIRUS RESISTANCE; VIRUS TRANSMISSION; VIRUS TYPING; VIRUS VIRULENCE;

EID: 0043066625     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13049407     Document Type: Review

References (56)

1. Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, Detours V. Evolutionary and immunological implications of contemporary HIV-1 combination. Br Med Bull 2001;58:19-42.
2. Quiñones-Mateu M, Arts E. Recombination in HIV-1: update and implications. AIDS Reviews 1999;1:89-100.
3. Janini L, Tanuri M, Schechter M, Peralta J, Vicente A, De la Torre N, et al. Horizontal and vertical transmission of HIV type 1 dual infections caused by viruses of subtypes B and C. J Infect Dis 1998;177:227-31.
4. Mellquist J, Becker-Pergola G, Gu J, Guay L, Himes L, Kataaha P, et al. Dual transmission of subtype A and D HIV type 1 viruses from Uganda woman to her infant. AIDS Res Hum Retroviruses 1999;15:217-21.
5. Díaz R, Sabino E, Mayer A, Mosley J, Busch M. Dual HIV type 1 infection and recombination in dually exposed transfusion recipient. J Virol 1995;69:3273-81.
6. Blackard J. Cohen D, Mayer K. HIV superinfection and recombination: current state of knowledge and potential clinical implications. Clin Infect Dis 2002; 34:1108-14.
7. Fultz P, Srinivasan A, Greene C, Butler D, Swenson R, McClure H. Superinfection of a chimpanzee with a second strain of HIV. J Virol 1987;61:4026-9.
8. Vernazza P, Eron J, Cohen M, Van der Horst C, Troiani L, Fiscus S. Detection and biologic characterization of infectious HIV-1 in semen of seropositive men. AIDS 1994;8:1325-9.
9. Royce R, Seña A, Cates W, Cohen M. Sexual transmission of HIV. N Engl J Med 1997;336:1072-8.
10. Quinn T, Wawer M, Sewankambo N, Serwadda D, Li C, Wabwire-Mangen F, et al. Viral load and heterosexual transmission of HIV type 1. N Engl J Med 2000;342:921-9.
11. Gray R, Wawer M, Brookmeyer R, Sewankambo N, Serwanda D, Wabwire-Mangen F, et al. Probability of HIV transmission per coital act in monogamus, heterosexual, HIV-1 discordant couples in Rakai, Uganda. Lancet 2001;357:1149-53.
12. Chakraborty H, Sen P, Helms R, Vernazza P, Fiscus S, Eron J, et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 2001;15:621-7.
13. Colfax G, Buchbinder S, Cornelisse P, Vittinghoff E, Mayer K, Celum C. Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. AIDS 2002;16:1529-35.
14. Tanfer K, Aral S. Sexual intercourse during menstruation and self-reported sexually transmitted disease history among women. Sex Transm Dis 1996;23:395-401.
15. Henin Y, Mandelbrot L, Henrion R, Pradinaud R, Coulaud JP, Montagnier L. Virus excretion in the cervicovaginal secretions of pregnant and non-pregnant HIV-infected women. J Acquir Immune Defic Syndr 1993;6: 72-5.
16. Cohen M. Sexually transmitted diseases enhance HIV transmission: no longer a hypotesis. Lancet 1998;351(Suppl 3):5-7.
17. Morgan D, Mahe C, Okongo J, Mayanja B, Whitworth J. Genital ulceration in rural Uganda: sexual activity, treatment, seeking behaviour, and the implications for HIV control. Sex Transm Dis 2001;28:431-6.
18. Dean M, Carrington M, Winkler C, Huttley G, Smith M, Allikmets R, et al. Genetic restriction of HIV-1 infection and progression to AIDS by deletion allele of CCR5 structural gene. Science 1996;273:1856-62.
19. Soto-Ramirez L, Renjifo B, McLane M, Marlink R, O'Hara C, Sutthent R, et al. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996;271:1291-3.
20. Pope M, Frankel S, Mascola J, Trkola A, Isdell F, Birx D, et al. HIV type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-cell mixtures without displaying subtype-specific tropism. J Virol 1997;71:8001-7.
21. Overbaugh J, Kreis J, Poss M, Lewis P, Mostad S, John G, et al. Studies of HIV type 1 mucosal viral shedding and transmission in Kenya. J Infect Dis 1999;179:401-4.
22. Hart A, Cloyd M. Interference patterns of HIV-1 and HIV-2. Virology 1990;177:1-10.
23. Taddeo B, Federico M, Titti F, Rossi G, Verani P. Homologous superinfection of both producer and non-producer HIV-1-infected cells is blocked at a late transcription step. Virology 1993;194:441-52.
24. Little S, Riggs N, Chowers M, Fitch N, Richman D, Spina C, et al. Cell surface down-modulation of CD4 after infection by HIV-1. Virology 1994;205:578-82.
25. Potash M, Volsky D. Viral interference in HIV-1 infected cells. Rev Med Virol 1998;8:203-10.
26. Barker E, Bossart K, Locher C, Patterson B, Levy J. CD8+ cells from asymptomatic HIV-infected individuals suppress superinfection of their peripheral blood mononuclear cells. J Gen Virol 1996;77:2953-62.
27. Kannagi M, Masuda T, Hattori T, Kanoh T, Nasu K, Yamamoto N, et al. Interference with HIV replication by CD8+ T cells in peripheral blood leukocytes of asymptomatic HIV carriers in vitro. J Virol 1990;64:3399-406.
28. Makedonas G, Bruneau J, Lin H, Sékaly R, Lamothe F, Bernard N. HIV-specific CD8 T-cell activity in uninfected injection drug users is associated with maintenance of seronegativity. AIDS 2002;16:1595-602.
29. Mazzoli S, Trabattoni D, Lo Caputo S, Piconi S, Ble C, Meacci F, et al. HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nat Med 1997;3:1250-7.
30. Kaul R, Plummer F, Kimani J, Dong T, Kiama P, Rostron T, et al. HIV-1-specific mucosal CD8+ lymphocyte responses in the cervix of HIV-1-resistant prostitutes in Nairobi. J Immunol 2000;164:1602-11.
31. Kaul R, Trabattoni D, Bwayo J, Arienti D, Zagliani A, Mwangi F, et al. HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999;13:23-9.
32. Le Guern M, Levy J. HIV type 1 can superinfect HIV-2 - infected cells: pseudotype virions produced with expanded cellular host range. Proc Natl Acad Sci USA 1992;89:363-7.
33. Kim J, Mosca J, Vahey M, McLinden R, Burke D, Redfield R. Consequences of HIV type 1 superinfection of chronically infected cells. AIDS Res Hum Retroviruses 1993;9:875-82.
34. Gratton S, Cheynier R, Dumaurier M, Oksenhendler E, Wain-Hobson S. Highly restricted spread of HIV-1 and multiply infected cells with splenic germinal centers. Proc Natl Acad Sci USA 2000;97:14566-71.
35. Wei Q, Fultz P. Extensive diversification of HIV type 1 subtype B strains during dual infection of a chimpanzee that progressed to AIDS. J Virol 1998;72:3005-17.
36. Otten R, Ellenberger D, Adams D, Fridlund C, Jackson E, Pieniazek D, et al. Identification of a window period of susceptibility to dual infection with two distinct HIV type 2 isolates in a Macaca Nemestrina (pigtailed macaque) model. J Infect Dis 1999;180:673-84.
37. Cranage M, Sharpe S, Whatmore A, Polyanskaya N, Norley S, Cook N, et al. In vivo resistance to simian immunodeficiency virus superinfection depends on attenuated virus dose. J Gen Virol 1998;79:1935-44.
38. Kyaw-Tanner M, Robinson W. Quasispecies and naturally occurring superinfection in feline immunodeficiency virus infection. Arch Virol 1996; 141:1703-13.
39. Van de Woude S, Hageman C, O'Brien S, Hoover E. Nonpathogenic lion and puma lentiviruses impart resistance to superinfection by virulent feline immunodeficiency virus. J AIDS 2002;29:1-10.
40. Sarr A, Sankale J, Gueye-Ndiaye A, Essex M, Mboup S, Kanki P. Genetic analysis of HIV type 1 in monotypic and dual infections. AIDS Res Hum Retroviruses 2000;16:295-8.
41. Andersson S, Norrgren H, Dias F, Biberfeld G, Albert J. Molecular characterization of HIV-1 and - 2 in individuals from Guinea-Bissau with single or dual infections: predominance of a distinct HIV-1 subtype A/G recombinant in West Africa. Virology 1999;262:312-20.
42. Travers K, Mboup S, Marlink R, Gueye-Nidaye A, Siby T, Thior I, et al. Natural protection against HIV-1 infection provided by HIV-2. Science 1995;268:1612-5.
43. Dern K, Rubsamen-Waigmann H, Unger R. Inhibition of HIV type 1 replication by simultaneous infection of peripheral blood lymphocytes with HIV types 1 and 2. AIDS Res Hum Retroviruses 2001;17:295-309.
44. Greenberg A. Possible protective effect of HIV-2 against incident HIV-1 infection: review of available epidemiological and in vitro data. AIDS 2001;15:2319-21.
45. Angel J, Kravcik S, Balaskas E, Yen P, Badley A, Cameron D, et al. Documentation of HIV-1 superinfection and acceleration of disease progression. 7th Conference on Retroviruses and Opportunistic Infections; 2001, January 30-February, San Francisco, CA [abstract LB2].
46. Ramos A, Hu D, Nguyen L, Hu D, Nguyen L, Phan K, et al. Intersubtype HIV type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol 2002;76: 7444-52.
47. Jost S, Bernard M, Kaiser L, Yerly S, Hirschel B, Samri A, et al. A patient with HIV-1 superinfection. N Engl J Med 2002;347:731-6.
48. Altfeld M, Allen TM, Yu XG, Johnston MN, Agrawal D, Korber BT, et al. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature 2002;420:434-9.
49. Chakraborty B, Valer L, Rangel H, Weber J, Stoddart C, Lederman M, et al. Evaluating HIV-1 superinfection in cell culture, the SCID-hu Thy/Liv model and HIV-infected individuals with high risk of re-exposure to the viruses. Antiviral Therapy 2002;7(Suppl):47.
50. Hu W, Temin H. Genetic consequences of packaging two RNA genomes in one retroviral particle: pseudodiploidy and high rate of genetic recombination. Proc Natl Acad Sci USA 1990;87:1556-60.
51. Li W, Tanimura M, Sharp P. Rates and dates of divergence between AIDS virus nucleotide sequence. Mol Biol Evol 1988;5:313-30.
52. Domingo E, Holland J. Mutation rates and rapid evolution. 1994. En: Morse S, editor. The evolutionary biology of viruses. New York: Raven Press, 161-84.
53. Kellam P, Larder B. Retroviral recombinant can lead to linkage of reverse transcriptase mutations that confer increased zidovudine resistance. J Virol 1995;69:669-74.
54. Gu Z, Gao Q, Faust E, Wainberg M. Possible involvement of cell fusion and viral recombination in generation of HIV variants that display dual resistance to AZT and 3TC. J Gen Virol 1995;76:2601-5.
55. Moutouh L, Corbeil J, Richman D. Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc Natl Acad Sci USA 1996;93:6106-11.
56. Hosseinipour M, Cohen M, Vernazza P, Kashuba A. Can antiretroviral therapy be used to prevent sexual transmission of HIV-1? Clin Infect Dis 2002;34:1391-5.